Awareness Technology Showcases Range of Cutting-Edge Analyzers
By LabMedica International staff writers Posted on 12 Nov 2024 |

Awareness Technology, Inc. (Palm City, FL, USA) is showcasing its advanced analyzers at MEDICA 2024 where these instruments are available for hands-on demonstrations during the show.
At this year’s MEDICA, Awareness is presenting the ChemWell 2 two-plate ELISA/chemiluminescent analyzer for running a variety of applications. The instrument’s ability to mix a wide range of ELISA/CLIA assays on two microwell plates provides a level of flexibility that makes the ChemWell 2 an excellent choice for laboratories. Awareness is also showcasing the ChemWell RPR Automated RRP Analyzer for serum syphilis screening that utilizes a sophisticated camera system designed to capture high-resolution images of the reactions. It features specialized software that analyzes the image, providing an accurate and objective reading of the reaction as reactive or non-reactive.
Also being presented at the show are the enhanced Stat Fax 4500 biochemistry analyzer and Stat Fax 4700 ELISA strip reader which have recently received upgraded screens, faster processors, and new user interfaces. At the heart of the Stat Fax 4500 and 4700 is a new and faster micro-processor and significantly increased memory capacity. All the calculation modes, reporting functions, and the ability to customize test parameters remain the same but function faster. A new feature of the instruments’ improved memory capacity is their ability to store over 140 programmed tests. Their new interface features a high-resolution backlit display with a capacitive touch screen that has the responsiveness of a smartphone with no need for a stylus to make accurate selections. Screens are updated almost instantly with a new menu system driven by icons designed to intuitively identify their functions.
At MEDICA 2024, Awareness is also introducing its latest instrument, the Chemi+ biochemistry analyzer designed to optimize laboratory efficiency. This compact device boasts a small footprint, making it an ideal choice for labs with limited space. The Chemi+ is complemented by user-friendly software, ensuring seamless operation for lab technicians of all skill levels. A standout feature of the Chemi+ is its open system capability, which allows for wireless management of up to four Chemi+ analyzers through a single tablet or PC. This integration not only simplifies workflow but also enhances productivity by enabling simultaneous multi-device operation. The Chemi+ biochemistry analyzer is poised to set a new standard in laboratory technology, combining efficiency, ease of use, and advanced connectivity in a compact design.
Related Links:
Awareness Technology, Inc.
Latest Medica 2024 News
- EDAN Instruments Highlights Range of Lab Analyzers, ECG Devices and Ultrasound Systems
- BioVendor Group Introduces Groundbreaking Immunological Biomarker
- Getein Biotech Showcases Latest POCT Analyzers
- Fapon Highlights Innovative IVD Total Solutions and Localization Services
- Wondfo Presents Advanced Solutions in CLIA Testing and Blood Gas Analysis
- Globe Scientific Exhibits Cutting-Edge Solutions for Meeting Laboratory Needs
- LGC Clinical Diagnostics Presents Seraseq and ACCURUN Range of Diagnostic Solutions
- Oruba Showcases Innovative Self-Operating Uroflowmeter
- Sentinel Diagnostics Presents Latest Breakthroughs in Diagnostics
- Alcor Scientific Presents Latest Innovation in High Volume ESR Testing
- CerTest Showcases Latest Innovations in Diagnosis of Infectious Diseases
- Vircell Presents Latest Offerings and Products in Diagnostic Testing
- Tianlong Demonstrates Latest Biochemistry, Immunology, POCT and Molecular Diagnostic Products
- EKF Presents Cutting-Edge Point-Of-Care Diagnostic Solutions
- Vedalab Exhibits Rapid Diagnostic Tests
- Meridian Showcases Innovative Solutions for Molecular Diagnostics and Immunoassays
Channels
Clinical Chemistry
view channel
‘Brilliantly Luminous’ Nanoscale Chemical Tool to Improve Disease Detection
Thousands of commercially available glowing molecules known as fluorophores are commonly used in medical imaging, disease detection, biomarker tagging, and chemical analysis. They are also integral in... Read more
Low-Cost Portable Screening Test to Transform Kidney Disease Detection
Millions of individuals suffer from kidney disease, which often remains undiagnosed until it has reached a critical stage. This silent epidemic not only diminishes the quality of life for those affected... Read more
New Method Uses Pulsed Infrared Light to Find Cancer's 'Fingerprints' In Blood Plasma
Cancer diagnoses have traditionally relied on invasive or time-consuming procedures like tissue biopsies. Now, new research published in ACS Central Science introduces a method that utilizes pulsed infrared... Read moreMolecular Diagnostics
view channel
Blood Biomarker Test Could Detect Genetic Predisposition to Alzheimer’s
New medications for Alzheimer’s disease, the most common form of dementia, are now becoming available. These treatments, known as “amyloid antibodies,” work by promoting the removal of small deposits from... Read more
Novel Autoantibody Against DAGLA Discovered in Cerebellitis
Autoimmune cerebellar ataxias are strongly disabling disorders characterized by an impaired ability to coordinate muscle movement. Cerebellar autoantibodies serve as useful biomarkers to support rapid... Read more
Gene-Based Blood Test Accurately Predicts Tumor Recurrence of Advanced Skin Cancer
Melanoma, an aggressive form of skin cancer, becomes extremely difficult to treat once it spreads to other parts of the body. For patients with metastatic melanoma tumors that cannot be surgically removed... Read moreHematology
view channel
New Scoring System Predicts Risk of Developing Cancer from Common Blood Disorder
Clonal cytopenia of undetermined significance (CCUS) is a blood disorder commonly found in older adults, characterized by mutations in blood cells and a low blood count, but without any obvious cause or... Read more
Non-Invasive Prenatal Test for Fetal RhD Status Demonstrates 100% Accuracy
In the United States, approximately 15% of pregnant individuals are RhD-negative. However, in about 40% of these cases, the fetus is also RhD-negative, making the administration of RhoGAM unnecessary.... Read moreImmunology
view channel
Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer
Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more
Machine Learning-Enabled Blood Test Predicts Immunotherapy Response in Lymphoma Patients
Chimeric antigen receptor (CAR) T-cell therapy has emerged as one of the most promising recent developments in the treatment of blood cancers. However, over half of non-Hodgkin lymphoma (NHL) patients... Read moreMicrobiology
view channel
Handheld Device Delivers Low-Cost TB Results in Less Than One Hour
Tuberculosis (TB) remains the deadliest infectious disease globally, affecting an estimated 10 million people annually. In 2021, about 4.2 million TB cases went undiagnosed or unreported, mainly due to... Read more
New AI-Based Method Improves Diagnosis of Drug-Resistant Infections
Drug-resistant infections, particularly those caused by deadly bacteria like tuberculosis and staphylococcus, are rapidly emerging as a global health emergency. These infections are more difficult to treat,... Read more
Breakthrough Diagnostic Technology Identifies Bacterial Infections with Almost 100% Accuracy within Three Hours
Rapid and precise identification of pathogenic microbes in patient samples is essential for the effective treatment of acute infectious diseases, such as sepsis. The fluorescence in situ hybridization... Read morePathology
view channel
Novel UV and Machine Learning-Aided Method Detects Microbial Contamination in Cell Cultures
Cell therapy holds great potential in treating diseases such as cancers, inflammatory conditions, and chronic degenerative disorders by manipulating or replacing cells to restore function or combat disease.... Read more
New Error-Corrected Method to Help Detect Cancer from Blood Samples Alone
"Liquid biopsy" technology, which relies on blood tests for early cancer detection and monitoring cancer burden in patients, has the potential to transform cancer care. However, detecting the mutational... Read more
"Metal Detector" Algorithm Hunts Down Vulnerable Tumors
Scientists have developed an algorithm capable of functioning as a "metal detector" to identify vulnerable tumors, marking a significant advancement in personalized cancer treatment. This breakthrough... Read more
Novel Technique Uses ‘Sugar’ Signatures to Identify and Classify Pancreatic Cancer Cell Subtypes
Pancreatic cancer is often asymptomatic in its early stages, making it difficult to detect until it has progressed. Consequently, only 15% of pancreatic cancers are diagnosed early enough to allow for... Read moreTechnology
view channel
Disposable Microchip Technology Could Selectively Detect HIV in Whole Blood Samples
As of the end of 2023, approximately 40 million people globally were living with HIV, and around 630,000 individuals died from AIDS-related illnesses that same year. Despite a substantial decline in deaths... Read more
Pain-On-A-Chip Microfluidic Device Determines Types of Chronic Pain from Blood Samples
Chronic pain is a widespread condition that remains difficult to manage, and existing clinical methods for its treatment rely largely on self-reporting, which can be subjective and especially problematic... Read more
Innovative, Label-Free Ratiometric Fluorosensor Enables More Sensitive Viral RNA Detection
Viruses present a major global health risk, as demonstrated by recent pandemics, making early detection and identification essential for preventing new outbreaks. While traditional detection methods are... Read moreIndustry
view channel
Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions
Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Grifols and Tecan’s IBL Collaborate on Advanced Biomarker Panels
Grifols (Barcelona, Spain), one of the world’s leading producers of plasma-derived medicines and innovative diagnostic solutions, is expanding its offer in clinical diagnostics through a strategic partnership... Read more